44 results
DEF 14A
KYMR
Kymera Therapeutics Inc
30 Apr 21
Definitive proxy
8:30am
ENDING DECEMBER 31, 2021
CORPORATE GOVERNANCE
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
PRINCIPAL STOCKHOLDERS
REPORT OF THE AUDIT COMMITTEE … operations, policies or practices.
Our Nominating and Corporate Governance Committee Policies and Procedures for Director Candidates, or the Director
8-K
KYMR
Kymera Therapeutics Inc
9 Sep 20
Departure of Directors or Certain Officers
4:30pm
of Directors or Certain Officers; Election of Directors.
On September 4, 2020, upon the recommendation of the Nominating and Corporate Governance Committee … of Nasdaq. Dr. Esposito was also appointed to serve on the Nominating and Corporate Governance Committee of the Board. Effective as of September 4, 2020
8-K
csfd3cs
18 Jan 22
Departure of Directors or Certain Officers
4:06pm
8-K
15u35rb8xahcdj 7j
8 Jul 22
Departure of Directors or Certain Officers
7:45am
8-K
il3a yhm1p1vd4j0xlam
16 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
azdgl
1 Apr 24
Departure of Directors or Certain Officers
7:00am
8-K
cbmqi w7w525dtzlxcb3
3 Nov 22
Kymera Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Business Update
7:17am
424B4
ewsv9 7mwdib44f1e
2 Jul 21
Prospectus supplement with pricing info
4:09pm
DRS
fpryy
17 Mar 21
Draft registration statement
12:00am
8-K
EX-99.1
3ytucowyaz2j19
9 Aug 22
Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update
7:10am